Drug Profile
t2c 003
Alternative Names: t2c003; t2c003-NPLatest Information Update: 06 Oct 2011
Price :
$50
*
At a glance
- Originator t2cure
- Developer Johann Wolfgang Goethe Universitatsklinikum
- Class Stem cell therapies
- Mechanism of Action Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic neuropathies
Most Recent Events
- 25 Jan 2006 Phase-I/II clinical trials in Diabetic neuropathies in Germany (Intra-arterial)